RightCare, Sensiotec Named Winners of Inaugural Innovation Contest

Share Article

National Readmission Prevention Collaborative selects technology and software winner for first annual Innovation Contest

News Image
“We are very pleased with this prestigious award," siad Mr. Arkin.

The National Readmission Prevention Collaborative Announced today that two innovations stood out above the other entries and were named winners of its first annual National Readmission Prevention Collaborative Innovation Contest.

Sensiotec, has developed the world’s first, completely non-contact patient monitoring solution. A web-enabled, FDA-510(k) Class II-cleared and FCC-certified biosensor panel is placed unobtrusively under a patient’s bed at the point of care, providing a completely passive patient monitoring experience unencumbered by electrodes, pads, tape or wearables that touch the skin or otherwise require direct or indirect contact with the patient.

RightCare Solutions, a care transitions software technology company focused on reducing readmissions and optimizing post-acute care delivery for hospitals and health systems, was named the winner in the software category. RightCare assesses patient risk and post-acute care needs at the time of admission, ensures the appropriate plan is in place and seamlessly transitions patient information to post-acute care providers and community partners. RightCare is proven to reduce hospital readmissions, length of stay and excess days.

"It was amazing to see all the different technologies and innovations out there, but Sensiotec and RIghtcare stood out above the rest," said Dr. Josh Luke, Founder of the National Readmission Prevention Collaborative."Our newsletter list has grown to more than 100,000 healthcare providers in less than 18 months and the response to our initial Innovation Contest was overwhelming. It's not just the technology that made these two stand out, but both are user friendly and extremely affordable solutions. Both products benefit providers across the continuum, not just acute providers."

“We are honored to be recognized as a leading innovator by NRPC, a nationally recognized organization in the field of care transitions. It is the RightCare commitment to ensure patients get the right care in the right environment, minimizing avoidable readmissions and improving patient outcomes through evidence-based technology”.

“We are very pleased that the National Readmission Prevention Collaborative has recognized, with this prestigious award, the important contribution that Sensiotec’s non-contact patient monitoring solution can bring to providers across the continuum," said Robert Arkin, Sensiotec’s founder and CEO. We believe the application of this technology will represent a disruptive innovation that improves patient care and outcomes, increases patient safety, and controls costs, and, in the process, helps move healthcare where it needs to go.”

About The National Readmission Prevention Collaborative
The National Readmission Prevention Collaborative was created to showcase Best Practice care coordination case studies. The website, http://www.NationalReadmissionPrevention.com, has the most comprehensive set of care coordination case studies on the web, showcased for providers around the world to access best practices. the NRPC website also has a readmission certification for healthcare professionals and tool kits to improve care coordination and reduce unnecessary hospital admissions.

About Sensiotec
Sensiotec is reinventing patient monitoring with Virtual Medical Assistant® (VMA), a scalable, non-contact, clinical mHealth patient monitoring solution that combines our award-winning, ambient biosensor panel with a HIPAA-compliant cloud server and proprietary web applications. By providing actionable, high value, low cost, accurate patient data at any time, any place, our solution can improve quality of patient care and outcomes, increase patient safety, and control costs to support aging in place, optimize clinical resources and improve pay-for-performance metrics and outcomes. And with our Biosensor as a Service (BAAS) revenue model, it’s totally affordable. Sensiotec is based at Georgia Tech’s Advanced Technology Center (ATDC) in Atlanta, Georgia. Recently, the company received the Impact Award for Emerging Mega Trends from the Southeastern Software Association. In 2014, the company received the Phoenix Award for Start-up of the Year from the Metro Atlanta Chamber of Commerce and the “Best of the Best” Top 10 Innovation Award and the People’s Choice Award for Breakthrough Technology from the Technology Association of Georgia. Sensiotec has also received the Healthcare Heroes Award for Innovation.

END

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Ford Phillips

Robert Arkin
Visit website